Hype or hope? The developing evidence base for psychedelic treatment of addiction disorders.
The British journal of psychiatry : the journal of mental science – March 21, 2025
Source: PubMed
Summary
Recent studies highlight the promising role of psychedelics in treating addictions. Clinical trials show these compounds can significantly reduce substance use disorders, offering hope for effective, evidence-based mental health solutions. This emerging approach could reshape addiction treatment and improve patient outcomes.
Abstract
There has been substantial recent renewed interest and investment to assess the therapeutic potential of psychedelic compounds in addiction disorders. This editorial discusses the available evidence from randomised trials and future research directions in the field, together with potential implications for patients, professionals and the wider addiction treatment system.